Influence of bioengineered skin substitutes on diabetic foot ulcer and venous leg ulcer outcomes.

Journal of wound care

Volumn 17, Issue 12, 2008, Pages 517-527

  Barber, C ^a   Watt, A ^a   Pham, C ^a   Humphreys, K ^a   Penington, A ^a   Mutimer, K ^a   Edwards, M ^a   Maddern, G ^a  

^a ROYAL AUSTRALASIAN COLLEGE OF SURGEONS   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APLIGRAF; BIOBRANE; BIOMATERIAL; COLLAGEN; TRANSCYTE; UNCLASSIFIED DRUG;

ARTIFICIAL SKIN; CHRONIC DISEASE; CULTURE TECHNIQUE; DIABETIC FOOT; HEALTH SERVICE; HUMAN; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SAFETY; SKIN TRANSPLANTATION; STANDARD; TREATMENT OUTCOME; VARICOSIS; WOUND HEALING;

CELL CULTURE TECHNIQUES; CHRONIC DISEASE; COATED MATERIALS, BIOCOMPATIBLE; COLLAGEN; DIABETIC FOOT; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SAFETY; SKIN TRANSPLANTATION; SKIN, ARTIFICIAL; TREATMENT OUTCOME; VARICOSE ULCER; WOUND HEALING;

EID: 60849117852     PISSN: 09690700     EISSN: None     Source Type: Journal    
DOI: 10.12968/jowc.2008.17.12.31766     Document Type: Review

References (37)